1.
Urol Int
; 104(3-4): 269-272, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31480046
RESUMO
Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We report a series of 3 cases of crizotinib-associated renal cysts in patients admitted to our institution, with different kinds of presentation. A monitor for complex renal cysts is warranted in patients receiving crizotinib.